Research Article

Related GMR Articles

Aptamer; Nasopharyngeal carcinoma; SELEX

To screen the nucleic acid aptamers of the EB virus-positive nasopharyngeal carcinoma cells, we used SELEX technology and synthesized in vitro a 78-nucleotide random DNA library. We used normal nasopharyngeal epithelial cells and EB virus-positive low differentiated nasopharyngeal carcinoma cells as target to conduct 10 cycles of screening, cloning, sequencing, and identification ... more

W.X. Chen; K.H. Zhang; X.S. Zou; Y.Q. Chen; J.G. Li
CNE2 cell line; Nasopharyngeal carcinoma; Sexual dimorphism; STGC3

STGC3 is a potential tumor suppressor in nasopharyngeal carcinoma. We previously found that CNE2 cells that re-expressed STGC3 formed smaller tumors in female mice than in male mice. Here, we investigated the sexual dimorphism of STGC3 as a tumor-suppressor in female and male nude mice injected subcutaneously with pcDNA3.1(+)-STGC3/CNE2 cells. ER-α was ... more

Q. Qiu; B. Hu; Z.C. Chen; X.S. He
Clinical outcome; Nasopharyngeal carcinoma; p53 codon 72

We conducted a cohort study to investigate whether polymorphisms in p53 at codon 72 are associated with tumor response and survival time of advanced nasopharyngeal carcinoma (NPC) patients treated with radiotherapy. The study population included 127 subjects with NPC who were enrolled at Binzhou Medical University between September 2008 and December 2009. Cox proportional hazard ... more

M.L. Li; Y. Dong; Y.Z. Hao; N. Xu; F.L. Ning; S.S. Chen; J.M. Yu
Cyclin D1; Nasopharyngeal carcinoma; Survivin

The association between cyclin D1 and survivin protein expressions with radiotherapy sensitivity in patients with nasopharyngeal carcinoma was investigated. Biopsy specimens of 72 patients with nasopharyngeal carcinoma were collected before the initiation of radiotherapy (49 cases were in the radiation-sensitive group and 23 cases were in the radiation-insensitive group). Conventional ... more

S.M. Fu; M.X. Xu; S.M. Lin; Z. Liang; J.H. Cai
Concurrent chemoradiotherapy; Curative effect; Overall survival; Excision repair cross-complementing gene 1 (ERCC1); Nasopharyngeal carcinoma

In this study, the expression of DNA excision repair cross-complementing gene 1 (ERCC1) in local advanced nasopharyngeal carcinoma has been correlated with the efficacy of concurrent chemoradiotherapy. A total of 76 patients diagnosed with undifferentiated nasopharyngeal carcinoma diagnosed by nasopharyngeal biopsy and undergoing single-agent cisplatin chemotherapy (80 mg/m2) with ... more

R. Liang; Y. Lin; Z.H. Liu; X.L. Liao; C.L. Yuan; S.N. Liao; Y.Q. Li
Gene silencing; Nasopharyngeal carcinoma; siRNA; Survivin

We examined the function of survivin gene expression in patients with nasopharyngeal carcinoma (NPC), as well as small interfering RNA (siRNA) on controlling CNE-2 NPC proliferation and apoptosis. Immunohistological methods, in situ hybridization, and reverse transcription-polymerase chain reaction technique were used to detect survivin protein and mRNA expression. We designed ... more

S.M. Fu; Z.H. Tu; L.Q. Deng; J.H. Cai; Z. Liang; Z.Q. Lin; Y.T. Wang